All In Biotech

Drug Trial Radar · NCT02026817

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 750/10 mg and Coadministration of Metformin SR 750 mg and Rosuvastatin 10 mg in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Mar 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Dec 2013

Primary completion

Dec 2013

Study completion Jan 2014

Sponsor

Sponsor type
Industry
First posted
Jan 3, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 20 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To compare the pharmacokinetic characteristics between HCP1201 tablet 750/10 mg and co-administration of metformin 750 mg plus rosuvastatin 10 mg under fed state condition.

Conditions

  • Diabetes Mellitus

Interventions

  • HCP1201 750/10mgDrug

    750mg Metformin/10mg rosuvastatin fixed dose combination tablet orally in the morning on day1 or day8.

  • Metformin SR 750mgDrug

    Co-administration of Metformin 750mg and Rosuvastatin 10mg orally in the morning on day1 or day8.

  • Rosuvastatin 10mgDrug

    Co-administration of Metformin 750mg and Rosuvastatin 10mg orally in the morning on day1 or day8.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. metformin, rosuvastatin CmaxTime frame: pre-dose, post-dose 0.5, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 24, 48 h
  2. metformin, rosuvastatin AUClastTime frame: pre-dose, post-dose 0.5, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 24, 48 h

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Samsung Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.